COVID-19 Implications
Disclaimer
Document scope
Agenda
Overview of COVID-19
Governments response
Challenges
Near-term changes
emergency regulations
APAC economies
Key areas impacted
Key areas impacted
near-term impacts
current readiness
potential changes
healthcare capacity
self-sufficiency
Agenda
COVID-19’s impact
large pharmas
pharma activities
biotechs
biotech companies in APAC
Pharma services providers
CDMO reliance
medtech market
China medtech companies
APAC healthcare providers
Companies should assess
authors and APAC Life Sciences leaders
Connect with us
Related Practice
Life Sciences & Pharma

Related Insights